C8ORF39 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.914800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.296800E-01
Normal-vs-Stage2
5.074400E-01
Normal-vs-Stage3
3.961600E-01
Normal-vs-Stage4
9.694600E-01
Stage1-vs-Stage2
7.498800E-01
Stage1-vs-Stage3
7.584100E-02
Stage1-vs-Stage4
6.819600E-01
Stage2-vs-Stage3
6.943800E-03
Stage2-vs-Stage4
3.934200E-01
Stage3-vs-Stage4
2.944600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.359600E-01
Normal-vs-AfricanAmerican
3.620400E-01
Normal-vs-Asian
5.076200E-01
Caucasian-vs-AfricanAmerican
4.532600E-01
Caucasian-vs-Asian
2.265000E-01
AfricanAmerican-vs-Asian
8.477000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.735200E-01
Normal-vs-Female
5.248200E-01
Male-vs-Female
7.290000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.882600E-01
Normal-vs-Age(41-60Yrs)
6.987800E-01
Normal-vs-Age(61-80Yrs)
4.023800E-01
Normal-vs-Age(81-100Yrs)
4.945400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.205800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.782000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.511600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.553600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.754800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.886200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.594800E-01
Normal-vs-Daily Drinker
6.217600E-01
Normal-vs-Weekly Drinker
6.112400E-01
Normal-vs-Occasional Drinker
6.232800E-01
Normal-vs-Social Drinker
8.998000E-01
Non Drinker-vs-Daily Drinker
9.799200E-01
Non Drinker-vs-Weekly Drinker
8.775600E-01
Non Drinker-vs-Occasional Drinker
9.297200E-01
Non Drinker-vs-Social Drinker
5.179400E-01
Daily Drinker-vs-Weekly Drinker
8.904000E-01
Daily Drinker-vs-Occasional Drinker
9.055200E-01
Daily Drinker-vs-Social Drinker
4.874800E-01
Weekly Drinker-vs-Occasional Drinker
8.041800E-01
Weekly Drinker-vs-Social Drinker
4.660000E-01
Occasional Drinker-vs-Social Drinker
5.370800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.427800E-01
Normal-vs-Grade 2
1.145550E-01
Normal-vs-Grade 3
1.894630E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.656800E-01
Grade 1-vs-Grade 3
1.728990E-01
Grade 1-vs-Grade 4
2.427800E-01
Grade 2-vs-Grade 3
2.524800E-01
Grade 2-vs-Grade 4
1.145550E-01
Grade 3-vs-Grade 4
1.894630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.816000E-01
Normal-vs-NonDiabetic
4.665600E-01
Diabetic-vs-NonDiabetic
9.713400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.907600E-01
Normal-vs-NoPancreatitis
5.161800E-01
Pancreatitis-vs-NoPancreatitis
2.445800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.308400E-01
Normal-vs-N1
5.055400E-01
N0-vs-N1
7.193400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.711400E-01
Normal-vs-TP53-NonMutant
7.425400E-01
TP53-Mutant-vs-TP53-NonMutant
8.138200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
